TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc has reported changes in beneficial ownership involving its director, Carol Burt. The transaction involved the acquisition of 1,073 shares of ResMed common stock, with the shares awarded as Restricted Stock Units that will vest in full by November 2026 or at the next annual meeting of stockholders. This transaction highlights the company’s ongoing practices in stock-based compensation, which can impact shareholder value and executive incentives.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, particularly sleep apnea. The company is known for its innovative solutions in respiratory care, including devices and cloud-connected software applications that improve patient outcomes and reduce healthcare costs.
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.